180 related articles for article (PubMed ID: 24576578)
1. Applications of a 7-day Caco-2 cell model in drug discovery and development.
Peng Y; Yadava P; Heikkinen AT; Parrott N; Railkar A
Eur J Pharm Sci; 2014 Jun; 56():120-30. PubMed ID: 24576578
[TBL] [Abstract][Full Text] [Related]
2. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
3. Caco-2 cells as a model for intestinal absorption.
Angelis ID; Turco L
Curr Protoc Toxicol; 2011 Feb; Chapter 20():Unit20.6. PubMed ID: 21400683
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro models for the prediction of compound absorption across the human intestinal mucosa.
Miret S; Abrahamse L; de Groene EM
J Biomol Screen; 2004 Oct; 9(7):598-606. PubMed ID: 15475479
[TBL] [Abstract][Full Text] [Related]
6. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
[TBL] [Abstract][Full Text] [Related]
8. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers.
Hubatsch I; Ragnarsson EG; Artursson P
Nat Protoc; 2007; 2(9):2111-9. PubMed ID: 17853866
[TBL] [Abstract][Full Text] [Related]
9. Permeability for intestinal absorption: Caco-2 assay and related issues.
Press B; Di Grandi D
Curr Drug Metab; 2008 Nov; 9(9):893-900. PubMed ID: 18991586
[TBL] [Abstract][Full Text] [Related]
10. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.
Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146
[TBL] [Abstract][Full Text] [Related]
11. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model.
Delie F; Rubas W
Crit Rev Ther Drug Carrier Syst; 1997; 14(3):221-86. PubMed ID: 9282267
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In-house evaluation procedures.
Ingels F; Deferme S; Delbar N; Oth M; Augustijns P
J Pharm Belg; 2002; 57(6):153-8. PubMed ID: 12596572
[TBL] [Abstract][Full Text] [Related]
13. A modified fast (4 day) 96-well plate Caco-2 permeability assay.
Uchida M; Fukazawa T; Yamazaki Y; Hashimoto H; Miyamoto Y
J Pharmacol Toxicol Methods; 2009; 59(1):39-43. PubMed ID: 19049886
[TBL] [Abstract][Full Text] [Related]
14. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
[TBL] [Abstract][Full Text] [Related]
15. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption.
Shah P; Jogani V; Bagchi T; Misra A
Biotechnol Prog; 2006; 22(1):186-98. PubMed ID: 16454510
[TBL] [Abstract][Full Text] [Related]
16. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
17. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
Volpe DA
Future Med Chem; 2011 Dec; 3(16):2063-77. PubMed ID: 22098353
[TBL] [Abstract][Full Text] [Related]
18. Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
J Pharm Sci; 2016 Feb; 105(2):915-924. PubMed ID: 26869436
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.
Paixão P; Gouveia LF; Morais JA
Int J Pharm; 2012 Jun; 429(1-2):84-98. PubMed ID: 22449410
[TBL] [Abstract][Full Text] [Related]
20. Caco-2 cell permeability assays to measure drug absorption.
van Breemen RB; Li Y
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):175-85. PubMed ID: 16922635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
